Corporate Social Purpose

We’re not just focused on what we do – we care about how we do it. That’s why we are working to advance a responsible and environmentally-conscious approach that protects the world around us; a social justice and diversity, equity, and inclusion focus that empowers communities; and a culture that reflects the values our employees care about.

Canopy Growth’s purpose of “improving lives, ending prohibition, and strengthening communities” is our commitment to growing good together and articulates the strategic areas in which our company and brands are committed to making a positive impact on the world.

Improving Lives

UBC Professorship

Canada continues to experience an unprecedented public health emergency, where deaths from drug overdoses continue to be the leading cause of accidental death. In partnership with the British Columbia Ministry of Mental Health and Addictions, CGC has committed $2.5 million to the University of British Columbia (UBC) and the British Columbia Centre on Substance Use (BCCSU) to fund the Canopy Growth Professorship of Cannabis Science. The professorship is held by Dr. M-J Milloy and examines the potential utility of cannabis in addressing the overdose crisis and the potential benefits of cannabis as a legitimate therapeutic treatment for substance use.

Medical Cannabis Canada Patient Survey

Canopy Growth and Spectrum Therapeutics contributed an unrestricted, arms-length grant to support Medical Cannabis Canada (MCC), a leading, volunteer-run medical cannabis patient organization, to complete their first national patient survey. MCC will use these insights to advocate on behalf of patients with key stakeholders for the importance of a distinct medical stream, as well as where barriers can be reduced for patients to ensure reasonable access for all Canadians. This survey led to over 24 meeting requests from key stakeholders including federal and provincial governments, traditional patient groups, non-profit organizations and academia.

Canadian Aids Society – Clinical Practice Guidelines

Canopy Growth holds a multi-year partnership with the Canadian Aids Society, one of the first patient groups to champion medical cannabis access for patients in the early 2000s. Through this partnership, CAS has brought together 14 physicians, researchers and patients to develop evidence-informed clinical practice guidelines for the use of medical cannabis to manage chronic pain and associated symptoms. In 2020, CAS published the review protocol, which represents a key milestone in the medical community by documenting the rationale and planned process for the guidelines.

Undoing the Harms of Prohibition

National Expungement Works

Canopy Growth is proud to have supported National Expungement Works (N.E.W.) over the last three years, which brought expungement clinics and other forms of legal relief at events across 30 cities in the US to some of the 77 million Americans with convictions on their records. We stand united with those who are fighting for social equality, and have provided these organizations additional support for bail resources for protesters.

Americans for Safe Access

Canopy Growth is honoured to have supported Americans for Safe Access, one of the largest medical cannabis patient organizations, in sending over a dozen patients from across the world to the United Nations’s Commission on Narcotic Drugs (CND) in Vienna, Austria. Patients were able to participate in side events, meet with delegates regarding the importance of safe medical cannabis access and watch the CND deliberations.

Investing in Community

Wounded Warriors Canada Campaign

In November, during the month of collective remembrance, Spectrum Therapeutics initiated a fundraising campaign with a $50,000 grant to Wounded Warriors Canada, a national mental health organization that provides programming to Veteran, First Responders and their families. We also matched all donations from Canopy Growth staff and Spectrum Therapeutics’ customers, up to $20,000, to support WWC’s national group based trauma therapy programs and expanded program offerings to help mitigate the increased isolation and mental health impacts of COVID-19.

Supporting Connectivity in Long Term Care Facilities

In response to the increasing isolation in many long term care homes (LTCH) because of COVID-19, Spectrum Therapeutics sent a total of 57 iPads and iPad stands to 21 LTCH to help residents feel more connected to their family and friends. We also included iPad stands to assist staff when helping residents. We sent iPads to all LTCH involved in our Long Term Care Study, which is the largest study in the world, to date, on cannabis use in long term care. This donation builds on our legacy of making a positive impact in all the communities in which we operate through partnerships fostered at a local level.